Influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease

OBJECTIVE: Proton pump inhibitor (PPI) use has been associated with reduced diversity of the gut microbiome and may lead to worse clinical outcomes in inflammatory bowel disease (IBD). We aimed to evaluate whether PPI use affects clinical outcomes in a real-world setting. DESIGN: Healthcare claims d...

Descripción completa

Detalles Bibliográficos
Autores principales: Choden, Tenzin, Zhang, Hui, Sakuraba, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Gastroenterology & Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124315/
https://www.ncbi.nlm.nih.gov/pubmed/37070427
http://dx.doi.org/10.1080/07853890.2023.2198775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124315/
https://www.ncbi.nlm.nih.gov/pubmed/37070427
http://dx.doi.org/10.1080/07853890.2023.2198775

Ejemplares similares